Clinical Trials Browser

Phase 4 × Breast Neoplasms × Toremifene × Clear all

NCT02344940 2019-09-24

TTOS

Phase 4 Completed

Breast Neoplasms

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms